European Journal Of Nuclear Medicine And Molecular Imaging Impact Factor
The European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is a peer-reviewed medical journal that publishes original research articles, reviews, case reports, and editorials related to nuclear medicine and molecular imaging. This journal is the official publication of the European Association of Nuclear Medicine (EANM) and has been in publication since 1976.
What is Nuclear Medicine?
Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material to diagnose and treat various conditions and diseases. The radioactive material is administered to the patient through injection, ingestion, or inhalation and is detected by a special camera that creates images of the body's internal organs and tissues.
Nuclear medicine is used to diagnose and treat a wide range of conditions, including cancer, heart disease, gastrointestinal disorders, and neurological disorders. It is a safe and painless procedure that is widely used in hospitals and medical clinics around the world.
What is Molecular Imaging?
Molecular imaging is a type of medical imaging that uses specialized techniques to visualize and monitor the molecular and cellular processes in the body. It involves the use of various imaging modalities, such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI), to create images of the body at the molecular and cellular level.
Molecular imaging is used in a wide range of clinical applications, including cancer diagnosis and treatment, cardiovascular disease, neurology, and infectious diseases. It is a powerful tool for understanding the underlying mechanisms of disease and developing new treatments.
EJNMMI Impact Factor
The impact factor is a measure of the average number of citations that articles published in a particular journal receive over a two-year period. It is calculated by dividing the total number of citations by the total number of articles published in the journal during that period.
The European Journal of Nuclear Medicine and Molecular Imaging has a current impact factor of 7.704 (2020), making it one of the leading journals in the field of nuclear medicine and molecular imaging. This high impact factor is a testament to the quality of research published in the journal and its importance to the scientific community.
Why is EJNMMI important?
The European Journal of Nuclear Medicine and Molecular Imaging is an important resource for researchers, clinicians, and students in the field of nuclear medicine and molecular imaging. It provides a platform for the dissemination of cutting-edge research and advances in the field, as well as a forum for discussion and debate.
The journal publishes original research articles, reviews, case reports, and editorials, covering a wide range of topics in nuclear medicine and molecular imaging. It is a valuable resource for those involved in the diagnosis and treatment of various conditions and diseases, including cancer, cardiovascular disease, and neurological disorders.
Conclusion
The European Journal of Nuclear Medicine and Molecular Imaging is a leading publication in the field of nuclear medicine and molecular imaging. Its high impact factor is a testament to the quality of research published in the journal and its importance to the scientific community. The journal is an important resource for researchers, clinicians, and students in the field, providing a platform for the dissemination of cutting-edge research and a forum for discussion and debate.